Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy

✍ Scribed by Fridrik, M. A.; Greil, R.; Hausmaninger, H.; Krieger, O.; Oppitz, P.; Stöger, M.; Klocker, J.; Neubauer, M.; Helm, W.; Pont, J.; Fazeny, B.; Hudec, M.; Simonitsch, I.; Radaszkiewicz, T.

• Book ID: 121556172
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 124 KB
• Volume: 93
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-013-1983-y